The World Professional Association of Transgender Health (WPATH), the world's leading organization setting standards for transgender medical care, faces mounting scrutiny after internal forum messages obtained through a public records request revealed members discussing the need for formalized protocols to treat patients who wish to detransition, according to reporting by The Daily Wire. The disclosure comes as the Federal Trade Commission filed a lawsuit against WPATH in June 2026 alleging the organization misled parents and children about medical interventions.
The Daily Wire obtained nearly 250 pages of messages from WPATH's member-only forum spanning June through November 2024 through a public records request. In one thread titled "De-transition Protocols/Policies," Dr. Christopher Terndrup, associate director of the LGBTQ+ Healthcare Fellowship Program at Vanderbilt Health, asked whether any institutions had developed protocols for patients seeking to reverse gender-affirming surgeries or return to prior hormonal states.
What the Left Is Saying
Progressive advocates and medical professionals who support gender-affirming care argue that the existence of detransitioner discussions reflects responsible medical practice rather than evidence against treatment. They note that WPATH's Standards of Care Version 8 (SOC-8) explicitly advises clinicians to be prepared to support adolescents who detransition, suggesting transparency about potential outcomes.
Mental health professionals supporting expanded access to care emphasize that detransition represents a small minority of patients and often stems from external social pressure rather than regret with the medical intervention itself. They argue that restricting care based on cases would deny treatment to the vast majority of patients who benefit.
LGBTQ+ healthcare organizations contend that developing formal detransitioner protocols actually demonstrates the field's commitment to comprehensive, patient-centered care. They note that many medical specialties maintain protocols for reversing or adjusting previous interventions when patient circumstances change.
What the Right Is Saying
Conservative critics point to the FTC lawsuit as evidence that WPATH has systematically overstated the safety and effectiveness of interventions for minors. Dr. Kurt Miceli, chief medical officer at Do No Harm, a healthcare advocacy organization, told The Daily Wire there is an undeniable need for detransitioner protocols but questioned why such guidance was not developed earlier.
"This contradiction cannot be brushed aside: it exposes a fundamental inconsistency in which life-altering interventions are championed for minors on the one hand while the reality of those who later seek to reverse them has unfortunately been minimized and gone unaddressed," Miceli said.
Opponents of current standards argue that the private forum discussions reveal WPATH knew about gaps in care for detransitioners while publicly recommending irreversible procedures without age minimums. They contend this represents a failure of informed consent, particularly regarding minors who cannot fully understand long-term consequences.
What the Numbers Show
The FTC lawsuit, filed June 2026, alleges WPATH misrepresented medical consensus and necessity regarding child sex-change interventions. The SOC-8 recommends children have access to irreversible surgeries without specified age minimums for certain procedures.
In forum messages, one psychologist noted that patients restarting testosterone after detransitioning may experience mood shifts and that "a lot of regret arises about choices they have made." Another member wrote that detransitioners often felt they had to navigate their care "all on their own" due to lack of clinical guidance.
The Daily Wire reporting indicates WPATH characterizes the choice to detransition as proportionally rare, though no independent verification of prevalence rates was available in the source material.
The Bottom Line
WPATH faces legal and reputational challenges as the FTC lawsuit proceeds. The internal forum messages provide a contrast between public recommendations supporting broad access to interventions for minors and private acknowledgments that medical guidance for detransitioners remains underdeveloped.
Healthcare providers, policymakers, and insurers who rely on SOC-8 guidelines may face increased scrutiny over whether current standards adequately address informed consent and long-term patient outcomes. Watch for developments in the FTC lawsuit and any potential revisions to professional guidelines as both sides of this debate continue to engage with the medical evidence.